No Data
Active and newly listed stocks during the morning session.
* ID & EHD <9161> 5380 yen - The spread continues at the TOB price of 6500 yen by Tokio Marine. * Kosaido HD <7868> 505 +51, expecting demand improvement due to a share buyback. * JCR Pharma <4552> 692 +54, particularly no material but possibly inflow of funds from institutions. * LIFUL <2120> 174 +10, a sense of value but no particular materials observed. * Mitsuura Industry <6584> 797 +41, for datacenter water.
Stocks that moved the previous day part 1: Quolis, ID & EHD, KADOKAWA, etc.
Stock Name <Code> 20-day closing price ⇒ Day before GeoCode <7357> 652 +41.25. For the fiscal year ending March 2005, an increase of 5 yen is expected compared to the previous year, including the 20th anniversary commemorative dividend. Morito <9837> 1511 +67.2, upward revision of the dividend estimate for the fiscal year ending November 2024, and announcement of the presentation of the 35th anniversary commemorative gift. Rohto Pharma <4527> 2718 -68.5, Foreign securities firms downgrade their investment rating by 2 levels. Qualipps <4894> 4975 +70.0, partial submission of clinical-related application documents to PMDA, with approval application submission.
The Tokyo Stock Exchange Growth Index is slightly down, with limited buying back and lacking directional strength.
Tokyo Stock Exchange Growth Market Index 808.58 -0.06 / volume 0.2 billion 32.71 million shares / trading value 129 billion yen. Tokyo Stock Exchange Growth Market 250 Index 631.16 -0.05 / volume 0.1 billion 10.44 million shares / trading value 95.2 billion yen. Today's growth market saw minor declines in the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, with 248 advancing stocks, 293 declining stocks, and 45 unchanged. The growth market today experienced heavy trading at the upper levels. From the previous day on the 19th, the market in the usa.
Emerging markets stock digest: Qualipus, Orcs hit the daily limit up.
<7140> PetGo 770 +39 continues to rise significantly. It has announced the acquisition of up to 0.06 million shares (0.05 billion yen) of its own shares. The proportion to the total number of issued shares (excluding treasury shares) is 3.33%. The acquisition period is from the 20th to March 31, 2025, in order to implement a flexible capital policy in response to changes in the business environment. The share buyback is well received as a shareholder return strategy, and since hitting the year-to-date low on the 15th, the stock price has stopped falling, indicating a bottom.
Qualips --- Hit the ceiling price, submitted part of clinical-related application materials to PMDA, speculation on approval application.
It has been announced that there was a stop high. On the 18th, the Pharmaceuticals and Medical Devices Agency (PMDA) was visited to submit part of the clinical-related application documents and to receive additional questions from the PMDA. It is scheduled to submit responses to those questions and additional clinical-related application documents between late November and early December. In June, QualiPs disclosed that it would apply for approval of iPS cell-derived cardiac cell sheets for ischemic cardiomyopathy within this year, raising investor expectations in connection with this visit.
The Tokyo Stock Exchange Growth Index rebounded significantly, attracting attention to emerging stocks.
TSE Growth Market Index 808.64 +14.59 / volume 0.2 billion 15.63 million shares / trading value 120.7 billion yen TSE Growth Market 250 Index 631.21 +11.95 / volume 86.49 million shares / trading value 89.1 billion yen Today's growth market saw a significant rebound in the TSE Growth Market Index and the TSE Growth Market 250 Index, with 387 stocks rising, 161 stocks falling, and 43 remaining unchanged. The growth market had a steady performance today. The previous day's US market on the 18th.
No Data
No Data